Study: NCT00715910

Adverse event: Appendicitis
Serious: yes
Organ System: Infections and infestations
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 1 affected / 183 at risk

Adverse event: Depression
Serious: yes
Organ System: Psychiatric disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 1 affected / 183 at risk

Adverse event: Malaria
Serious: yes
Organ System: Infections and infestations
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 1 affected / 183 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 100 affected / 170 at risk

Adverse event: Erythema
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 39 affected / 170 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 27 affected / 170 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 58 affected / 170 at risk

Adverse event: Gastrointestinal symptoms
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 28 affected / 170 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 61 affected / 170 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 3 affected / 183 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 20 affected / 37 at risk

Adverse event: Erythema
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 6 affected / 37 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 5 affected / 37 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 7 affected / 37 at risk

Adverse event: Gastrointestinal symptoms
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 8 affected / 37 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 10 affected / 37 at risk

Adverse event: Upper respiratory tract infection
Serious: no
Organ System: Infections and infestations
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 2 affected / 38 at risk

Adverse event: Pain
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 55 affected / 91 at risk

Adverse event: Erythema
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 17 affected / 91 at risk

Adverse event: Swelling
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 14 affected / 91 at risk

Adverse event: Fatigue
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 30 affected / 91 at risk

Adverse event: Gastrointestinal symptoms
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 20 affected / 91 at risk

Adverse event: Headache
Serious: no
Organ System: General disorders
Notes: Assessed during the 6 months period following vaccination in booster phase
Frequency: 22 affected / 91 at risk